PRTK

Paratek Pharmaceuticals, Inc.

Delisted

PRTK was delisted on the 20th of September, 2023.

0 hedge funds and large institutions have $0 invested in Paratek Pharmaceuticals, Inc. in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
Holders Change
-66
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
66
Calls
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$113K
Name Holding Trade Value Shares
Change
Shares
Change %
Jane Street
51
Jane Street
New York
-$32.4K -14,668 Closed
CL
52
CSS LLC
Illinois
-$30.9K -14,000 Closed
PCM
53
Perkins Capital Management
Minnesota
-$30K -13,700 Closed
C
54
Covestor
United Kingdom
-$25K -11,184 Closed
LPL Financial
55
LPL Financial
California
-$23.4K -10,605 Closed
Baird Financial Group
56
Baird Financial Group
Wisconsin
-$23.1K -10,435 Closed
KWM
57
Kingsview Wealth Management
Oregon
-$22.1K -10,000 Closed
UBS Group
58
UBS Group
Switzerland
-$18.3K -8,284 Closed
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
-$10K -4,776 Closed
Osaic Holdings
60
Osaic Holdings
Arizona
-$9.47K -4,292 Closed
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
-$2.46K -1,112 Closed
PA
62
Parallel Advisors
California
-$1.66K -750 Closed
Fidelity Investments
63
Fidelity Investments
Massachusetts
-$928 -420 Closed
TRCT
64
Tower Research Capital (TRC)
New York
-$221 -100 Closed
HI
65
Harbour Investments
Wisconsin
-$4 -2 Closed